Steven Cohen Pacific Biosciences Of California, Inc. Transaction History
Point72 Asset Management, L.P.
- $44.6 Billion
- Q2 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 914,190 shares of PACB stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
914,190Holding current value
$1.11 Million% of portfolio
0.0%Shares
14 transactions
Others Institutions Holding PACB
# of Institutions
243Shares Held
199MCall Options Held
893KPut Options Held
840K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl36.3MShares$43.9 Million0.37% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$28.6 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M020.5MShares$24.7 Million0.11% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA16.8MShares$20.3 Million2.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$19.4 Million0.0% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $272M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...